Algorithmic Drug Design
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
60
NCT04777981
(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC
Phase: N/A
Role: Lead Sponsor
Start: Jul 1, 2022
Completion: Dec 28, 2022
Loading map...